Fig. 2From: Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey studyParticipant-reported effects of cannabinoid-based medicines on epidermolysis bullosa-related A symptoms and disease process, B well-being and C pain types. Data is ordered by frequency of much improved. N = 48 responses are included. Items indicated as not applicable by participants are removedBack to article page